- Home
- AIRE vs ECOR Comparison
AIRE vs ECOR Comparison
Compare AIRE & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- ECOR
- Stock Information
- Founded
- AIRE 2021
- ECOR 2005
- Country
- AIRE United States
- ECOR United States
- Employees
- AIRE N/A
- ECOR N/A
- Industry
- AIRE
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AIRE
- ECOR Health Care
- Exchange
- AIRE Nasdaq
- ECOR Nasdaq
- Market Cap
- AIRE 39.4M
- ECOR 37.1M
- IPO Year
- AIRE N/A
- ECOR 2018
- Fundamental
- Price
- AIRE $1.12
- ECOR $5.00
- Analyst Decision
- AIRE Hold
- ECOR Strong Buy
- Analyst Count
- AIRE 1
- ECOR 2
- Target Price
- AIRE N/A
- ECOR $25.50
- AVG Volume (30 Days)
- AIRE 33.3M
- ECOR 53.5K
- Earning Date
- AIRE 11-11-2025
- ECOR 11-12-2025
- Dividend Yield
- AIRE N/A
- ECOR N/A
- EPS Growth
- AIRE N/A
- ECOR N/A
- EPS
- AIRE N/A
- ECOR N/A
- Revenue
- AIRE $3,043,657.00
- ECOR $27,700,000.00
- Revenue This Year
- AIRE $410.32
- ECOR $24.48
- Revenue Next Year
- AIRE $166.28
- ECOR $44.35
- P/E Ratio
- AIRE N/A
- ECOR N/A
- Revenue Growth
- AIRE 2973.28
- ECOR 30.16
- 52 Week Low
- AIRE $0.14
- ECOR $4.16
- 52 Week High
- AIRE $4.49
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- AIRE 67.84
- ECOR 45.01
- Support Level
- AIRE $1.13
- ECOR $4.70
- Resistance Level
- AIRE $1.42
- ECOR $5.14
- Average True Range (ATR)
- AIRE 0.20
- ECOR 0.25
- MACD
- AIRE 0.08
- ECOR 0.03
- Stochastic Oscillator
- AIRE 52.48
- ECOR 29.50
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.